EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:142936 - α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))
| Formula | C101H171N6O61R |
| Net Charge | 0 |
| Average Mass (excl. R groups) | 2445.446 |
| Monoisotopic Mass (excl. R groups) | 2444.04632 |
| SMILES | *C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7NC(C)=O)[C@H]6O[C@@H]6O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]6O)[C@H](O)[C@H]5NC(C)=O)[C@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7NC(C)=O)[C@H]6O[C@@H]6O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]6O)[C@H]5NC(C)=O)[C@H]4O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142936) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142936) is a α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide (CHEBI:142935) |
| Synonyms | Source |
|---|---|
| α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-acylsphing-4E-enine | SUBMITTER |
| α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-acylsphingosine | SUBMITTER |
| α-L-Fuc-(1→2)-(α-D-GalNAc-(1→3))-β-D-Gal-(1→3)-β-D-GlcNAc-(1→3)-[α-L-Fuc-(1→2)-(α-D-GalNAc-(1→3))-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→3)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(d18:1(4E)) | SUBMITTER |
| UniProt Name | Source |
|---|---|
| lacto IV3-(a-Fuc1-2-(a-GalNAc1-3)-b-Gal1-3-b-GlcNAc),IV6-(a-Fuc1-2-(a-GalNAc1-3)-b-Gal1-4-b-GlcNAc)-Lc4Cer(d18:1(4E)) | UniProt |